Compound ID | 816
Class: Oxazolidinone
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Protein synthesis inhibitor |
| Institute where first reported: | Johnson & Johnson Pharmaceutical Research & Development, NJ |
| Year first mentioned: | 2000 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/substance/349988068 |
| Citation: | https://doi.org/10.1016/S0960-894X(01)00305-5 |